University of Pennsylvania
John Q. Trojanowski, M.D., Ph.D.
Funded Research
| Project Description | Researchers | Funding |
|---|---|---|
|
Support of Central Spinal Fluid Biomarker Study–ADNI
Cure Alzheimer's Fund is part of a funding consortium supporting collaborative biomarker investigation of the elevation of tau and decreased concentrations of Amyloid beta 42 in the Central Spinal Fluid as evidence of the presence of the Alzheimer's disease pathology. |
2008 |
Selected Publications
These published papers resulted from Cure Alzheimer’s Fund support.
, The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement, Alzheimer's & Dementia, 5 Dec 2016
, Identifying amyloid pathology–related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study, Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 1(3), September 2015, 339-348
, Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014, Alzheimer's & Dementia, 11(7), July 2015, 865-884
© 2005-2017 Cure Alzheimer's Fund. All rights reserved.